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The third part of the study, a collabo-
rative venture with the Centers for Disease
Control and Prevention (CDC), funds a
variety of disease prevention programs at
several university-based centers nation-
wide. With the particular goal ofincluding
women of diverse races and lower socio-
economic status, these projects focus on
such issues as improving delivery of dia-
betes care, reducing cardiovascular risk
among black women, and measuring phys-
ical activity in women. This arm ofthe ini-
tiative began in 1995 and will run on a
five-year funding period.
To date, approximately 65,000 women
have enrolled in the observational and clin-
ical trials at 40 centers around the country.
The director of the initiative, Loretta
Finnegan, says the investigators aim to
have 164,500 participants by 1998. The
study will be completed in 2005, at which
point researchers will analyze data. They
expect to provide results by 2007.
This is the largest study ofwomen ever
undertaken and the numbers involved can
become overwhelming. To manage the
project on all levels, the NIH established
one central coordinating center in Seattle,
Washington. Staffat the center manage all
data from that location, aided by a com-
puter network. "All of our sites are con-
nected all the time by a network," explains
Garnet Anderson, a project director for
data coordination at the center. Thus,
Anderson can freely access data from all 40
clinical centers.
Because the initiative extends over such
a long period, the scientists must continual-
ly reevaluate the research protocol and inte-
grate new data as they become available.
Judith Ashley, a study investigator and
assistant professor in the Department of
Medicine at University ofCalifornia at Los
Angeles, is impressed with the adaptability
built into the study. As an example, when
recent research results indicated that
women who have not had a hysterectomy
should not take estrogen without proges-
terone because of increased incidence of
cervical dysplasia, the investigators respond-
ed quickly and changed the study design.
The WHI is approximately one-third
of the way through its projected life span.
So far, outside organizations are optimistic
about the project. "We are pleased that
NIH is taking on a comprehensive study of
women's health," said Lisa Cox, program
director for the National Women's Health
Network, a public interest group devoted
to giving women a stronger voice in the
nation's healthcare system. "We hope the
study will finally provide answers to ques-
tions that have been posed for a very long
time-questions such as the relationship
between hormone replacement therapy
and breast cancer."
According to Luella Klein, director of
women's health issues for the American
College ofObstetrics and Gynecology, the
initiative has already provided benefits by
calling attention to gender in research.
"Partly because ofthe uproar that was gen-
erated [before the creation of the WHI,
when the NIH realized that only about
13% of research funding was going to
female-specific research], there are data
now coming out that never would have
come out before, because nobody ever
bothered to divide data by men and
women.
While Klein is enthusiastic about the
initiative, she voices concern about its size.
In this time of budget cuts, such a mam-
moth endeavor makes an easy target. Klein
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says she has seen other large studies discon-
tinued prematurely and worries that the
WHI could be another victim. "I hope
they make it to the end and that modifica-
tions are made as needed," she said.
Since 1993, women ranging in age
from 50 to 79 have been signing up to par-
ticipate in this landmark study. Many may
not live to see the final results. But as
Ashley comments, "They're concerned
about their children and their grandchil-
dren. They [participate in] the examina-
tions and the trial because they care about
themselves and other women.
National Strategy on
Endocrine Disruptors
Mounting scientific evidence and recent
media attention have heightened public
awareness about endocrine disruptors,
chemicals that mimick or interfere with the
actions of hormones. Exposures to high
doses of these chemicals, such as
organochlorine compounds including
DDT, PCBs, and dioxins, can be strongly
associated with declines in offspring,
increases in cancers, and reductions in
reproductive functions in wildlife and
humans. Because the various research pro-
jects on endocrine disruptors conducted by
federal agencies lack cohesion, the govern-
ment is working to coordinate and inte-
grate research needs and goals.
The White House Office of Science
and Technology Policy's Committee on
Environment and Natural Resources
(CENR) has created an interagency task
force to develop a national strategy for
research on endocrine disruptors. The
goals of the working group include identi-
fying key scientific questions about
endocrine disruptors; developing an inven-
tory of current federal research programs
on endocrine disruptors; identifying
research gaps in ongoing programs and
assessing research needs to facilitate coor-
dination across the federal government;
initiating outreach efforts to public inter-
est, private sector, and international
groups; and promoting educational activi-
ties to disseminate information to the sci-
entific community. The working group is
chaired by Lawrence Reiter, director ofthe
EPA's National Health and Environmental
Effects Research Laboratory. George
Lucier, director of the Environmental
Toxicology Program ofthe NIEHS, serves
as vice chair for human health and
Michael Mac, program manager for status
and trends for the National Biological
Survey of the Department of the Interior,
serves as vice chair for ecology.
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Research Area Research Need
Basic Research Dissection ofdirect immune-endocrine interactions
Understanding of cellular and molecular mechanisms
Sensitive, inexpensive, and widely available analytical tools
Understanding the biological significance of subtle low-dose effects
Identify and characterize critical windows ofsusceptibility across species
Characterize source of population heterogeneity in dose responsiveness
(age, gender, nutrition, etc.)
Exposure Determination Rapid andinexpensive Xposure moitorng ithodsforuse inwildlf
populatns
Increased moniong efots to id if statsndtrends Of
EDs
Environmental causes ofliver, brain, and lung cancers
Mixtures Research to address the additivity principle for mixtures
In vitro and in vivostudies of complex mixtures to evaluate validity ofTEQs
Identification andtesting ofenvironmentally relevant mixtures
Systematic evaluation ofspecies, cellular, and age dependent response to
mixtures of EDs
MultidisciplinaryStudies Systematicfieldandlabortorystudiesfbcused on criticaluncettainies
Examination ofcorrelaonofefts tiewildlif andmammian
models
Multidisciplinary studies on effectsofeidocrine disrupio
Examinato ofmuliple endpoin n mtip t o ED ao
Risk Models Statistical models to predict riskfrom exposure and effects
Improvements in study design
Evaluation oftoxicity and mechanistic endpoints across species
Toxicokinetics and toxicodynamic studies ofenvironmentally relevant
chemicals
Quantitative dose response models based upon receptor
theory/biochemical interactions
Establishmentoftraining programs in biomatheticsfor BBDRmodel
construction
Source: Adapted from Kavlock RJ et al., Research needs for the risk assessment of health and environ-
mental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health
Perspect, 104(Suppl 41:715-740 (1996).
"Although trends in hormonally related
diseases have not been clearly linked to
environmental chemicals, it is probable that
endocrine disruptors are contributing to
human diseases and dysfunction. The ques-
tion then becomes how much they are con-
tributing," Lucier said. "What is needed is
high-quality basic and applied research to
examine a number ofcritical areas."
Many individual federal agencies have
been working to develop research needs
and priorities. In April 1995, the EPA
sponsored an interdisciplinary workshop
on the human health and ecological effects
ofendocrine disruptors to identify research
gaps and determine future research priori-
ties. According to the workshop summary,
attendees concluded that research should
focus primarily on effects on development
of reproductive capability, on improved
exposure assessment, and on the effects of
mixtures. (See conference summary report,
Environmental Health Perspectives, August
1996.)
The goal of the CENR working group
is to evaluate and harmonize the needs and
priorities of the various agencies. Lucier
says that an interagency approach is impor-
tant to the development ofa national strat-
egy. "The most effective way to utilize basic
research to make sound policy decisions is
to develop interagency approaches that
maximize its application to multiple agen-
cies," he said. "We will develop cross-cut-
ting approaches useful
to all agencies." An
interagency approach
also maximizes com-
munication, Lucier
added.
The CENR group
has worked to put
together a document
prioritizing federal
research needs. Accord-
ing to a preliminary
draft of the strategy,
the highest priority is
determining the effects
ofendocrine disruptors
on developing organ-
isms, particularly on
the reproductive system. Other priorities
include assessing the potential carcinogenic
effects and the toxicology of mixtures and
assessing the nature and extent of contami-
nation in the area ofexposure. The group is
also working to develop a comprehensive
evaluation of all federally funded research
projects on endocrine disruptors. According
to Lucier, the group will also focus on how
to link scientific activities to public policy
decisions. The strategy is due out in
September.
Rewarding Cancer Research
Alfred G. Knudson, Jr., and Joseph F.
Fraumeni are this year's recipients of the
Irving J. Selikoff Award for Cancer
Research. Knudson and Fraumeni earned
the award specifically for "research on the
molecular origins ofcancer and its applica-
tion to the management of populations at
high risk," said Sheldon Samuels, vice pres-
ident for policy studies at the Ramazzini
Institute, which was founded by Selikoffto
promote occupational and environmental
health research. The Ramazzini Institute
sponsors the annual award.
Selikoff, who died in 1992, is remem-
bered for his work at NewYork's Mt. Sinai
School of Medicine in linking cancer and
other diseases with environmental pollu-
tants such as asbestos. The award consists
of a plaque and a monetary prize given
from a fund developed by Selikoff at the
Ramazzini Institute. "We decided to keep
the fund alive," Samuels said, adding that
the fund is entirely privately endowed. The
award is given to scientists who demon-
strate excellence in expanding genetic
research on how to repair cancer-causing
damage-to prevent cancer from later
appearing even though people have been
exposed in the past. The award recipients
are selected by a panel of officers at the
Ramazzini Institute.
Selikoff standouts. Alfred 6. Knudson, Jr. and Joseph F. Fraumeni (left to
right holding boxes) are the 1996 winners of the Irving J. Selikoff Award for
Cancer Research. They are flanked by Philip Landrigan (left) and Arthur C.
Upton (right) ofthe Mt. Sinai School of Medicine.
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